Résumé
Recently developed techniques for the direct analysis of DNA have made possible the determination of patterns of cellular X-chromosome inactivation. These techniques provide a potential method for carrier detection for several X-linked human disorders in which obligate carriers show nonrandom X inactivation. By using restriction fragment length polymorphic (RFLP) gene-specific probes in conjunction with methylation-sensitive enzymes, we have characterized the patterns of X-chromosome inactivation in cell subsets from females belonging to 10 kindreds segregating for the X-linked immune deficiency disorder Wiskott-Aldrich syndrome (WAS). We show that selective inactivation of the X chromosome distinguishes obligate WAS carriers from noncarrier females and constitutes a valuable marker of the WAS carrier state. Selective inactivation phenomena were observed in the monocytes and T and B lymphocytes of obligate carriers, implying that the WAS gene defect is expressed in each of these cellular lineages. In conjunction with the use of linked DNA markers, RFLP-methylation analysis should render carrier detection feasible for the majority of females from WAS families. The results of such analyses also provide an initial step toward identifying the cellular level and molecular basis for WAS.
Langue d'origine | English |
---|---|
Pages (de-à) | 60-67 |
Nombre de pages | 8 |
Journal | Genomics |
Volume | 4 |
Numéro de publication | 1 |
DOI | |
Statut de publication | Published - janv. 1989 |
Publié à l'externe | Oui |
Note bibliographique
Funding Information:We thank Drs. Douglas J. Jolly, Philip Leder, Hiroto Okayama, and Judith Singer-Sam for provision of probes: Francine Galli and Cheryl Smith for technical assistance; the WAS family members who contributed blood samples; the many colleagues who assisted in sample collection; and Drs. Louis Siminovitch, Lap-thee Tsui, and Huntington F. Willard for critical review. This work was supported by grants from the Medical Research Council of Canada (MA-9337) and the Hospital for Sick Children Foundation (87-02). Dr. Siminovitch is a recipient of a Career Scientist Award from the Ontario Ministry of Health and a Canadian Life and Health Insurance Agency Medical Scholarship. Dr. Rubin is an Associate of the Arthritis Society of Canada.
ASJC Scopus Subject Areas
- Genetics